LingVitae, Plarion and KTH Royal Institute of Technology Initiate Collaboration
News Mar 29, 2012
“Our aim with the Discipher is to democratise molecular and cellular analysis, putting low-cost easy to use tools in the hands of the wider community, outside of core laboratories”, said Dr Jackie Cole, Head of Marketing for Plarion.
As part of this engagement with KTH, LingVitae/Plarion will transfer prototype versions of the Discipher instrument to the researchers at KTH, as well as supporting the development work by customising the optical disc-based disposable assay devices.
“We look forward to the collaboration with Professor Lundeberg’s group. The track-record of KTH on development of DNA based assays, utilising a repertoire of molecular techniques, provides an exciting opportunity for us to expand our activities in the DNA assay space”, says Dr Preben Lexow, Chief Executive Officer of LingVitae.
Discipher is a low-cost, walk-away system, based on DVD technology. It uses self-contained, disposable assay devices in the form of DVD discs with microfluidic channels. The system has been jointly developed by UK-based Plarion Ltd and LingVitae, a Scandinavian life science company. This work has been supported by funding from the Seventh Research Framework Programme of the European Union, under the Digital Sequencing project (contract 222913).
“We see that the Discipher system addresses an unmet need in bringing DNA based diagnostics and testing to users who have previously had not access to this technology. We look forward the opportunity to strengthen our collaboration with both LingVitae and Plarion”, says Professor Lundeberg, based at the Science for Life Laboratory in Stockholm.
Gene Editing Technology May Improve Accuracy of Predicting Heart Disease RiskNews
Scientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies.READ MORE
Automated Robotic Device Enables Faster Blood TestingNews
Rutgers researchers have created an automated blood drawing and testing device that provides rapid results, potentially improving the workflow in hospitals and other health-related institutions to allow health care practitioners to spend more time treating patients.READ MORE
Comments | 0 ADD COMMENT
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018